
Ellen 't Hoen - @ellenthoen.bsky.social
@ellenthoen
I have moved to BlueSky. If you do too, you can follow me there: @ellenthoen.bsky.social
ID: 28312814
http://www.medicineslawandpolicy.org 02-04-2009 10:11:01
9,9K Tweet
6,6K Followers
1,1K Following

New HIV drug can only offer hope of ending AIDS if all have access, UNAIDS says (And Gilead Sciences can make that happen) unaids.org/en/resources/p…


Good The Lancet piece on the Pharmaceutical Accountability Foundation’s Stichting Farma ter Verantwoording legal case against AbbVie for its excessive pricing of Humira thelancet.com/action/showPdf…





Reviewing TRIPS, an opportunity for evidence-based policies, writes KM Gopakumar of Third World Network (and overdue) thehindubusinessline.com/specials/pulse…


Our big story this week: A potentially landmark court case on a cystic fibrosis treatment has been dropped following a price cut. The court was being asked to grant a compulsory license spotlightnsp.co.za/2024/08/06/cas… @tac James Packard Love, jamielove.bsky.social MSF Access Campaign Ellen 't Hoen - @ellenthoen.bsky.social SECTION27 Balasubramaniam


Monday, September 2nd, 2024 at 2 PM CEST: Reflections on the IP/Technology transfer provisions of the World Health Organization (WHO) Pandemic Agreement featuring James Packard Love, jamielove.bsky.social Ellen 't Hoen - @ellenthoen.bsky.social and Luis Villarroel #INB11 h/t Arianna Schouten


. World Health Organization (WHO) urges rapid access to #mpox diagnostic tests, invites manufacturers to emergency review who.int/news/item/29-0…

We scored a big win when J&J dropped their patent on #TB medicine after the CompComSA initiated a probe. 20 years ago, a similar case helped drive down #antiretroviral prices, write Fatima Hassan and Leena Menghaney. Health Justice Initiative - HJI MSF International Health Justice Initiative - HJI spotlightnsp.co.za/2024/08/30/com…

An HIV prevention drug that is 100% effective: this is a game-changer! Now to ensure lives over profit. Pleased to see The Lancet back UNAIDS Global' call for Gilead Sciences to make lenacapavir available rapidly & affordably to all who need in low- & middle-income countries.



Pharma is still struggling to widen access to medicines and reach patients, in LMICs. With some pointed quotes from Access to Medicine Foundation director Jayasree Iyer about the "big gap between what the companies say and what they do". statnews.com/pharmalot/2024… via STAT

In a new guest blog by @Kieranpharkin, @susanmsmith & James Larkin, we learn how members of the Irish College of General Practitioners made the momentous decision to stop accepting funding from the pharma industry. 📖Read the blog to find out more: haiweb.org/how-a-gp-group…


🆕 World Health Organization (WHO) Disease Outbreqk News #Marburg virus disease– The Republic of Rwanda who.int/emergencies/di…

